WOOJUNG BIO, Inc. Logo

WOOJUNG BIO, Inc.

Integrated R&D platform offering CRO services, lab construction, and biotech incubation.

215380 | KO

Overview

Corporate Details

ISIN(s):
KR7215380007
LEI:
Country:
South Korea
Address:
경기도 화성시 동탄기흥로 593-8 (영천동, 우정바이오 신약클러스터I), 화성시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

WOOJUNG BIO, Inc. is an integrated biopharmaceutical R&D solutions provider, operating as an open innovation platform for new drug development. The company's business is structured around three main pillars. Its Pre-clinical Contract Research Organization (CRO) delivers tailored services including efficacy studies, safety evaluations, and pharmaceutical analysis, utilizing its leading, AAALAC-accredited animal research facilities. The Engineering & Construction division provides comprehensive A-to-Z solutions for laboratory modernization, from design and construction of GMP facilities and clean rooms to ongoing maintenance. Additionally, its LAB CLOUD initiative functions as an R&D cluster, offering specialized labs, incubation, and acceleration support to biotech ventures and startups, facilitating the translation of innovative concepts into therapeutic applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-28 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 123.0 KB
2025-08-28 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 126.1 KB
2025-08-28 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-08-28 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-08-27 00:00
Major Shareholding Notification
최대주주변경
Korean 30.2 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.1 MB
2025-07-21 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-05-21 00:00
Board/Management Information
[기재정정]대표이사변경
Korean 14.6 KB
2025-05-16 00:00
Board/Management Information
대표이사변경
Korean 9.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 979.9 KB
2025-04-22 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 26.0 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 20.0 KB
2025-03-20 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 596.0 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 137.5 KB

Automate Your Workflow. Get a real-time feed of all WOOJUNG BIO, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for WOOJUNG BIO, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for WOOJUNG BIO, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CHAMPIONS ONCOLOGY, INC. Logo
Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.
United States of America
CSBR
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Logo
Global CRO for pharma & biotech, offering research models, safety testing & manufacturing solutions.
United States of America
CRL
Ch. Charilaou Group Plc Logo
A tour operator selling travel packages and developing online reservation platform solutions.
Cyprus
CHCH
Creates data-driven, integrated marketing and connected experiences for global brands.
South Korea
030000
Chiome Bioscience Inc. Logo
Clinical-stage biotech developing therapeutic antibodies and providing R&D services to partners.
Japan
4583
Chordia Therapeutics,Inc Logo
Developing first-in-class, small-molecule anti-cancer drugs targeting RNA deregulation.
Japan
190A
CHOSA Oncology AB Logo
Develops diagnostics and targeted therapies to personalize platinum-based cancer treatments.
Sweden
CHOSA
Cidara Therapeutics, Inc. Logo
Developing drug-Fc conjugates as targeted immunotherapies for cancer and serious infections.
United States of America
CDTX
CINC Corp. Logo
Offers AI marketing analytics and SEO tools leveraging a vast Japanese keyword dataset.
Japan
4378
CIRCULATION Co.,Ltd. Logo
Connects corporations with experts for project-based consulting to solve business challenges.
Japan
7379

Talk to a Data Expert

Have a question? We'll get back to you promptly.